SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for CEL SCI CORP (CVM) (CIK 0000725363) (CVM) — Feb 11, 2019

CEL SCI CORP (CVM) (CIK 0000725363)
Date: Feb. 11, 2019 · CIK: 0000725363 · Accession: 0000000000-19-001722

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-229295

Date
February 8, 2019
Author
Geert Kersten
Form
UPLOAD
Company
CEL SCI CORP (CVM) (CIK 0000725363)

Letter

February 8, 2019 Geert Kersten Chief Executive Officer CEL SCI CORP 8229 Boone Blvd. #802 Vienna, Virginia 22182 Re:CEL SCI CORP Registration Statement on Form S-1 Filed January 18, 2019 File No. 333-229295 Dear Mr. Kersten: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Todd Schiffman at 202-551-3491 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance

Show Raw Text
February 8, 2019
Geert Kersten
Chief Executive Officer
CEL SCI CORP
8229 Boone Blvd. #802
Vienna, Virginia 22182
Re:CEL SCI CORP
Registration Statement on Form S-1
Filed January 18, 2019
File No. 333-229295
Dear Mr. Kersten:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Todd Schiffman at 202-551-3491 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance